Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Shanghai Lianhe Investment

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 7
Average round size
info
The average size of a deal this fund participated in
$172M
Portfolio companies 7
Lead investments 1
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Manufacturing
  • Medical
  • Biopharma
  • Pharmaceutical
  • Biotechnology

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Acrew Louisiana, New Orleans, United States
Amdocs Chesterfield, Missouri, United States
BusinessInFact Andalucia, Sevilla, Spain
CoinCircle California, Santa Monica, United States
Lightbank Chicago, Illinois, United States
Livingston Securities New York, New York, United States
Sanyo Shokai -
Tappan Hill Ventures Ann Arbor, Michigan, United States
Tiburon Bayern, Germany, Munich
Tongsheng Touzi China, Shanghai

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Innostellar Biotherapeutics

11 Jun 2024 Shanghai, Shanghai, China

Jusheng Technology

19 Mar 2024 Baoshan, Shanghai, China

Yuanxin Satellite

Information and Communications Technology (ICT)
Information Technology
Satellite Communication
Telecommunications
$1B01 Feb 2024 Shanghai, Shanghai, China

Weiyan Medical

Biopharma
Health Care
Medical
Pharmaceutical
$15M29 Nov 2021 Beijing, Beijing, China

Electronics
Semiconductor
$100M06 Apr 2021 Shanghai, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Shanghai Lianhe Investment?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 7
Average round size 172M
Peak activity year 2024
Lead investments 1
Group Appearance index 0.71

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Innostellar Biotherapeutics

11 Jun 2024 Shanghai, Shanghai, China

Jusheng Technology

19 Mar 2024 Baoshan, Shanghai, China

Yuanxin Satellite

Information and Communications Technology (ICT)
Information Technology
Satellite Communication
Telecommunications
$1B01 Feb 2024 Shanghai, Shanghai, China

Weiyan Medical

Biopharma
Health Care
Medical
Pharmaceutical
$15M29 Nov 2021 Beijing, Beijing, China

Electronics
Semiconductor
$100M06 Apr 2021 Shanghai, China
Crunchbase icon

Content report

The following text will be sent to our editors: